Huons Global Co Ltd
KOSDAQ:084110
Relative Value
The Relative Value of one Huons Global Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 63 000 KRW, Huons Global Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Huons Global Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
H
|
Huons Global Co Ltd
KOSDAQ:084110
|
767.3B KRW | 0.9 | 31.5 | 5.4 | 8.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
932.9B USD | 14.3 | 45.2 | 30.5 | 32.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
578.6B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
271B CHF | 4.4 | 21 | 12.4 | 13.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
236.2B CHF | 5.4 | 21.8 | 13.5 | 17.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
224.8B GBP | 5.1 | 29.5 | 16.3 | 23 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
287.1B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.7 | 8 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.8B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121B USD | 2.5 | 17.2 | 7.2 | 8.9 |